CRISPR Therapeutics AG CRSP 深 滬
已收盤 05-08 16:00:00 美东时间
54.83
+2.410
+4.60%
華盛通- 最 高55.8499
- 今 開53.05
- 成交量 173.34万股
- 最 低 52.5501
- 昨 收 52.42
- 總市值 52.88亿
- 52周最高 78.48
- 市盈率 靜 --
- 換手率 1.80%
- 52周最低 35.38
- 委 比 -77.50%
- 總股本 9644.88万
- 歷史最高 220.20
- 量 比 0.88
- 振 幅 6.29%
- 歷史最低 13.50
- 每 手 1
- 風險率 8.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Citigroup Maintains Buy on CRISPR Therapeutics, Raises Price Target to $82
Citigroup analyst Yigal Nochomovitz maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and raises the price target from $80 to $82.
05-07 03:49
财报速睇 | CRISPR Therapeutics AG 2026财年Q1营收0.01亿美元，同比增长68.6%；归母净利润亏损1.23亿美元，同比亏损缩窄9.6%
华盛资讯5月5日讯，CRISPR Therapeutics AG公布2026财年Q1业绩，公司Q1营收0.01亿美元，同比增长68.6%，归母净利润亏损1.23亿美元，同比亏损缩窄9.6%。
05-05 12:02
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
CRISPR Therapeutics announced that its senior management will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. A live webcast will be available on the company's website, with a replay archived for 14 days. CRISPR Therapeutics, a biopharmaceutical leader, has developed transformative gene therapies, including CASGEVY® (exa-cel), the world's first CRISPR-based therapy for sickle cell disease and beta thalassemia. ...
04-07 12:00
Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Cathie Wood’s ARK Invest funds have delivered mixed performance in the recent period, with ARK Space & Defense Innovation ETF (ARKX) up 1.27% and ARK Autonomous Technology & Robotics ETF (ARKQ) margin...
04-04 02:25
奥博资本控股的「靖因药业-B」递表港交所，高盛、海通、汇丰护航
2026年3月31日，靖因药业第2次向港交所递交招股书，拟在香港主板上市，联席保荐人为高盛、海通国际及汇丰。公司曾于2025年9月28日向港交所递交招股书。 ...
04-02 15:08
新股消息 | 靖因药业二次递表港交所 核心产品SRSD107正于欧洲和中国开展II期多区域临床试验
据港交所3月31日披露，靖因药业(又称：Sirius Therapeutics)向港交所主板递交上市申请书，高盛、海通国际、HSBC为其联席保荐人。这是该公司第二次递表港交所。
04-01 07:13
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- Equity-Insider.com — A protein called α-Klotho circulating in the bloodstream protects the brain, heart, kidn...
03-24 23:05
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL
Cathie Wood’s Ark Invest reshuffled positions across its ETFs during last week, adding positions to gene-editing and AI healthcare names while trimming genomics tools and semiconductor equipment holdi...
03-16 19:05
